This paper presents lessons learned from previous flood responses in developing countries, based on a structured review of the literature. It is intended for people working in relief and recovery operations who have to decide if, when and how to intervene after a flood.
A Report on the Application of the HIV Stigma index in the Western highlands and Chimbu provinces
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome... them. The resulting documents
provide a framework to translate strategic intent into action
on integrating epidemiology, population, and cardiovascular outcome trial data into national plans for optimal
CVD management.
more
Resource Kit for Field workers
The context of the Ebola epidemic presented extreme challenges for Oxfam, as it did for many organisations. At the onset of the epidemic, there was a general lack of understanding of the disease and how to respond to it effectively and safely. A pervasive and persistent climate of fear, coupled with... changing predictions about the likely evolution of the epidemic, influenced analysis and response at all levels. There was strong pressure to treat the epidemic as a medical emergency requiring a medical response – organised through topdown processes – rather than standard humanitarian coordination
more
The funding requested in this supplementary appeal will enable UNHCR to enhance preventive, preparedness and response measures against EVD, participate in the regional and country inter-agency response and ensure continuity of operations, including preparations for the resumption of the voluntary re...patriation of Ivorian refugees, in the face of the Ebola crisis
more
For medical students and doctors
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda